The 2020 KDIGO CKD Guidelines in Diabetes - Prof. Hiddo L. Heerspink
Professor Hiddo L. Heerspink, PhD, PharmD University Medical Center Groningen, Netherlands Hiddo Lambers Heerspink is Professor of Clinical Trials and Personalized Medicine and a clinical trialist at the Department of Clinical Pharmacy and Pharmacology at the University Medical Center Groningen and visiting professor at the University of New South Wales in Sydney. He studied pharmacy at the University of Groningen and subsequently received his PhD from the University Medical Center Groningen. He worked as a Postdoctoral Fellow at The George Institute for Global Health, Sydney, Australia, where he investigated the effects of blood pressure-lowering regimens on renal and cardiovascular outcomes in patients with chronic kidney disease. Professor Lambers Heerspink’s research interests focus on optimizing current treatment strategies and finding new therapeutic approaches to halt the progression of renal and cardiovascular diseases in patients with diabetes with a specific focus on personalized medicine. He leads and participates in clinical trials focused on renal and cardiovascular complications of type 2 diabetes. His main expertise includes clinical trial design and personalized medicine as well as methodological aspects and statistical analyses of clinical trials. Professor L. Heerspink has received personal grants from the Netherlands Organisation of Scientific Research, the Young Investigator Research Award from the European Foundation for the Study of Diabetes, the Harry Keen award from the European Association for the study of Diabetes and several personal grants to develop novel strategies to improve the treatment for patients with type 2 diabetes and kidney complications. He is an editorial board member of the Clinical Journal of the American Society of Nephrology and served as guest editor for scientific journals including Diabetes Obesity & Metabolism and Nephrology Dialysis Transplantation. He has authored and co-authored over 250 peer-reviewed publications. This channel is the beginning of one of the many initiatives to be undertaken by Africa Healthcare Network(AHN) in the domain of education, training and research in nephrology in the African continent. AHN Website: http://www.africahealthcarenetwork.com/ AHN Facebook: / africahealthcarenetwork AHN Twitter: / africadialysis AHN Instagram: / africa_dialysis

Basics of Nutrition for CKD & Dialysis – Case Based Insights : Prof. Kelly Lambert : Series 157

Choice Restricted Conservative Kidney Management : Why is it important to get it right? : Series:152

Hypertension: Pearls for the Clinician : Prof. Yazied Chothia : Series 151

Dyslipidemia Masterclass Webinar Wave 2 : Guideline-Directed Therapy and Therapeutic Sequencing

Taking Metformin? You Were Never Told This...

Avoid These Vegetables If You Have Diabetes

Think Fast, Talk Smart: Communication Techniques

An Overview of “Monoclonal Gammapathy of Renal Significance (MGRS) : Series :149

What do tech pioneers think about the AI revolution? - The Engineers, BBC World Service

How to Speak

Lecture 13: Portfolio Management

Meet the Former CIA Agent Who Wants to Abolish the CIA

Doctor reveals undisclosed risks of COVID-19 vaccine

Get Rid of Insulin Resistance Once and for All (Eat This) | Dr. Boz

I’m a Pathologist: The "Biological Cost" of Ozempic and Mounjaro.

Changes In The Renal Diet - Case Based Insights :Dr. David St-Jules :Series -161

Evolution of Cardiac Diagnostics: A New Era with AI-Powered FFR-CT

Life begins at 40: the biological and cultural roots of the midlife crisis | The Royal Society

The #1 Fastest Way to Lower Insulin & Kill Visceral Fat - Dr. Jason Fung

